Titlebook: Neuropsychopharmacology; W. Wolfgang Fleischhacker,David J. Brooks Conference proceedings 2003 Springer-Verlag Wien 2003 Parkinson‘s disea

Strategy

书目名称Neuropsychopharmacology影响因子(影响力)




书目名称Neuropsychopharmacology影响因子(影响力)学科排名




书目名称Neuropsychopharmacology网络公开度




书目名称Neuropsychopharmacology网络公开度学科排名




书目名称Neuropsychopharmacology被引频次




书目名称Neuropsychopharmacology被引频次学科排名




书目名称Neuropsychopharmacology年度引用




书目名称Neuropsychopharmacology年度引用学科排名




书目名称Neuropsychopharmacology读者反馈




书目名称Neuropsychopharmacology读者反馈学科排名

陪审团每个人

Advances in the Pharmacological Management of Parkinson Disease,on. Finally preliminary reports suggest that Cholinesterase inhibitors, such as rivastigmine, can be usefull in the management of cognitive impairment in PD, one of the most difficult clinical problems encountered in the management of this neurodegenerative disorder.

把…比做

Autobiography

Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 recntrinsic activity, we show that the native H. receptor in brain displays high constitutive activity in vitro and, in vivo, controls the release of endogenous histamine. This implies that inverse agonists with high intrinsic activity should be preferred for therapeutic application as “cognitive enhancers” in several psychiatric disorders.

痛得哭了

BOOR

https://doi.org/10.1007/978-3-7091-6020-6Parkinson‘s disease; migraine; movement disorders; psychiatric disorders; schizophrenia; serotonin disord

证明无罪

978-3-211-83902-7Springer-Verlag Wien 2003

Agility

Neuropsychopharmacology978-3-7091-6020-6Series ISSN 0303-6995

防锈

0303-6995 Overview: 978-3-211-83902-7978-3-7091-6020-6Series ISSN 0303-6995

FORGO